MDPI and ACS Style
Ramos, E.; Palomino-Antolín, A.; Bartolini, M.; Iriepa, I.; Moraleda, I.; Diez-Iriepa, D.; Samadi, A.; Cortina, C.V.; Chioua, M.; Egea, J.;
et al. QuinoxalineTacrine QT78, a Cholinesterase Inhibitor as a Potential Ligand for Alzheimer’s Disease Therapy. Molecules 2019, 24, 1503.
https://doi.org/10.3390/molecules24081503
AMA Style
Ramos E, Palomino-Antolín A, Bartolini M, Iriepa I, Moraleda I, Diez-Iriepa D, Samadi A, Cortina CV, Chioua M, Egea J,
et al. QuinoxalineTacrine QT78, a Cholinesterase Inhibitor as a Potential Ligand for Alzheimer’s Disease Therapy. Molecules. 2019; 24(8):1503.
https://doi.org/10.3390/molecules24081503
Chicago/Turabian Style
Ramos, Eva, Alejandra Palomino-Antolín, Manuela Bartolini, Isabel Iriepa, Ignacio Moraleda, Daniel Diez-Iriepa, Abdelouahid Samadi, Carol V. Cortina, Mourad Chioua, Javier Egea,
and et al. 2019. "QuinoxalineTacrine QT78, a Cholinesterase Inhibitor as a Potential Ligand for Alzheimer’s Disease Therapy" Molecules 24, no. 8: 1503.
https://doi.org/10.3390/molecules24081503